Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Therma Bright Inc V.THRM

Alternate Symbol(s):  TBRIF

Therma Bright Inc. is a Canada-based company, which is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace. Its product offerings include Covid-19 diagnostic test product line, such as AcuVid COVID-19 Rapid Antigen Saliva Test and AcuVid COVID-19 Rapid Antibody Test; Sores & Bite Inflammation Therapy product line, such as InterceptCS Cold Sore Prevention System and TherOZap, and Muscle Pain & Blood Circulation Health Therapy product line, such as Venowave, which is a circulation booster designed to improve circulation in the lower extremities. Its products include Benepod, Inretio, AI4LYF, Invixa and Instatin, and others.


TSXV:THRM - Post by User

Bullboard Posts
Post by wwmeincon Aug 31, 2020 11:57am
213 Views
Post# 31479519

Ok...so we are now in the 'third party provider' game...

Ok...so we are now in the 'third party provider' game...which is just another marker on the road(ok...maybe a very long,long road it seems) to HC approval in the rapid/quick testing sector using saliva...information has always been key in the mkt and always will be...hopefully the company provides us with a few more clues while we all speculate as to whom/which firm the partnership will be working with....might be Cdn base(gov't funding seems to be freely available) or with Orpheus they look overseas to S.Korea/China,etc....I am agnostic; just act quickly and efficiently as THRM shareholders funds are at stake here(future dilution?)...glta


https://www.cbc.ca/news/canada/british-columbia/bc-covid-19-saliva-test-1.5607019


Bullboard Posts